Form 10-Q · Quarterly report
CME Group 10-Q, filed Jul 24, 2026
- Filed
- CIK
- 0001156375
- Accession no.
- 0001156375-26-000047
Summary
CME Group's second-quarter 2026 total revenues rose 1% year over year to $1.71 billion, with net income up 2% to $1.04 billion and diluted earnings per share of $2.88. For the first six months of 2026, revenues increased 8% to $3.59 billion and net income rose 11% to $2.20 billion.
Key points
- Second-quarter clearing and transaction fees fell 3% to $1.35 billion, while market data and information services revenue rose 20% to $238.1 million.
- Aggregate average daily contract volume was 29.843 million in the second quarter, down 1% from a year earlier.
- The average rate per contract for futures and options decreased to $0.678 in the second quarter from $0.690 a year earlier.
- Metals average daily volume rose in the second quarter, with silver up 43%, while energy volume fell 13%.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
ITEM 2. MANAGEMENT’S DISCUSSION RESULTS OF OPERATIONS Financial Highlights The following summarizes significant changes in our financial performance for the periods presented. Quarter Ended June 30, Six Months Ended June 30, (dollars in millions, except per share data) 2026 2025 Change 2026 2025 Change Total revenues $ 1,706.2 $ 1,692.0 1 % $ 3,586.3 $ 3,334.3 8 % Total expenses 599.1 562.7 6 1,169.5 1,097.0 7 Operating margin 64.9 % 66.7 % 67.4 % 67.1 % Non-operating income (expense) $ 220.6 $ 201.0 10 $ 421.8 $ 337.8 25 Effective tax rate 21.5 % 22.9 % 22.6 % 23.1 % Net income $ 1,041.8 $ 1,025.1 2 $ 2,196.1 $ 1,981.3 11 Diluted earnings per common share 2.88 2.81 2 6.06 5.43 12 Cash…
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.